Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tricida Inc (TCDA)

Tricida Inc (TCDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 568,557
  • Shares Outstanding, K 50,049
  • Annual Sales, $ 0 K
  • Annual Income, $ -176,810 K
  • 60-Month Beta 1.03
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -1.07
  • Number of Estimates 1
  • High Estimate -1.07
  • Low Estimate -1.07
  • Prior Year -0.89
  • Growth Rate Est. (year over year) -20.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.54 +19.08%
on 08/25/20
14.68 -22.62%
on 08/19/20
-2.99 (-20.84%)
since 08/18/20
3-Month
9.54 +19.08%
on 08/25/20
27.78 -59.11%
on 06/19/20
-15.86 (-58.27%)
since 06/18/20
52-Week
9.54 +19.08%
on 08/25/20
44.30 -74.36%
on 12/11/19
-22.80 (-66.74%)
since 09/18/19

Most Recent Stories

More News
Rosen, A Leading Law Firm, Announces Investigation of Securities Claims Against Tricida, Inc. - TCDA

New York, New York--(Newsfile Corp. - September 4, 2020) -  Rosen Law Firm, a global investor rights law firm, announces investigation of potential securities claims on behalf of shareholders of Tricida,...

TCDA : 11.36 (-2.99%)
TRICIDA ALERT: Bragar Eagel & Squire, P.C. is Investigating Tricida, Inc. on Behalf of Tricida Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Tricida, Inc. (NADSAQ: TCDA) on behalf of Tricida stockholders. Our investigation...

TCDA : 11.36 (-2.99%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Tricida, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) for violations...

TCDA : 11.36 (-2.99%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tricida, Inc. - TCDA

Pomerantz LLP is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or the "Company") (NASDAQ: TCDA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com...

TCDA : 11.36 (-2.99%)
EQUITY ALERT: ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Tricida, Inc. - TCDA

Rosen Law Firm, a global investor rights law firm, announces investigation of potential securities claims on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) resulting from allegations that Tricida...

TCDA : 11.36 (-2.99%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Tricida, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA) for violations...

TCDA : 11.36 (-2.99%)
EQUITY ALERT: ROSEN, A LEADING AND LONGSTANDING LAW FIRM, Announces Investigation of Securities Claims Against Tricida, Inc. - TCDA

Rosen Law Firm, a global investor rights law firm, announces investigation of potential securities claims on behalf of shareholders of Tricida, Inc. (NASDAQ: TCDA) resulting from allegations that Tricida...

TCDA : 11.36 (-2.99%)
Tricida Inc. Investors: Company Investigated by the Portnoy Law Firm

The Portnoy Law Firm advises Tricida Inc. ("Tricida" or the "Company") (NASDAQ: TCDA) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action...

TCDA : 11.36 (-2.99%)
TCDA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Tricida, Inc. Investors of Investigation and Encourages Investors to Contact the Firm

, /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tricida, Inc. ("Tricida" or "the Company") (NASDAQ: TCDA). Investors...

TCDA : 11.36 (-2.99%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tricida, Inc. - TCDA

, /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tricida, Inc. ("Tricida" or the "Company") (NASDAQ:  TCDA).   Such investors are advised to contact at or 888-476-6529,...

TCDA : 11.36 (-2.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade TCDA with:

Business Summary

Tricida, Inc. is a late-stage pharmaceutical company. It focuses on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular diseases. The company's product candidate consists of TRC101, a non-absorbed, orally-administered polymer drug designed to treat...

See More

Key Turning Points

2nd Resistance Point 12.31
1st Resistance Point 11.83
Last Price 11.36
1st Support Level 11.04
2nd Support Level 10.73

See More

52-Week High 44.30
Fibonacci 61.8% 31.02
Fibonacci 50% 26.92
Fibonacci 38.2% 22.82
Last Price 11.36
52-Week Low 9.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar